What do adenomyotic changes seen on ultrasound indicate and how should they be managed?

Adenomyotic Changes on Ultrasound

Adenomyotic changes on ultrasound indicate the presence of endometrial glands and stroma within the myometrium, a benign but often symptomatic condition that requires correlation with clinical presentation to guide management decisions.

What Adenomyosis Means

Adenomyosis is a structural cause of abnormal uterine bleeding where ectopic endometrial tissue infiltrates the myometrial wall 1. This is a benign gynecologic condition, not malignant, but can significantly impact quality of life through:

• Heavy menstrual bleeding
• Dysmenorrhea (painful periods)
• Chronic pelvic pain
• Infertility and adverse pregnancy outcomes 2, 3
• Approximately 30% of patients remain asymptomatic 3

Diagnostic Performance of Ultrasound

Transvaginal ultrasound (TVUS) is the first-line imaging modality for adenomyosis, with pooled sensitivity of 82.5% and specificity of 84.6% 1. However, diagnostic accuracy varies based on:

• Coexisting pathology: Sensitivity drops dramatically to 33.3% when leiomyomas are present (versus 97.8% without leiomyomas) 1
• Direct ultrasound signs are more reliable than indirect signs 4
• MRI has similar diagnostic performance (sensitivity ~78%, specificity ~93%) and should be considered when ultrasound is inconclusive 1

Key Ultrasound Features to Document

Direct signs (most specific):

• Echogenic subendometrial lines and buds - highest diagnostic value with sensitivity 83.3% and specificity 64.3% 5
• Myometrial cysts - low sensitivity (25%) but high specificity (85.7%) 5
• Asymmetric myometrial thickening
• Ill-defined junctional zone 6

Indirect signs (supportive but not definitive):

• Globular uterine morphology
• Diffusely enlarged uterus
• Heterogeneous myometrial echotexture 2, 4

Clinical Phenotypes Matter

Internal adenomyosis (affecting inner myometrium - 70% of cases):

• Presents diffusely with more ultrasound features
• Associated with globular uterus morphology
• More commonly coexists with leiomyomas
• Patients are typically older and parous 2

External adenomyosis (affecting outer myometrium - 30% of cases):

• More focal appearance
• Shows translesional vascularity on Doppler
• Strongly associated with deep endometriosis
• More common in nulliparous women 2

Management Algorithm

Step 1: Confirm Diagnosis and Assess Severity

• Perform TVUS combined with transabdominal ultrasound for complete uterine assessment 1
• Add Doppler evaluation as standard component 1
• Consider 3D ultrasound for spatial assessment and treatment planning 1
• If ultrasound is inconclusive or coexisting pathology obscures findings: Order MRI pelvis with gadolinium contrast and diffusion-weighted sequences 1

Step 2: Rule Out Malignancy

Critical pitfall: Adenomyosis can obscure endometrial visualization on ultrasound 1

• In postmenopausal women with bleeding: Endometrial thickness <4mm has nearly 100% negative predictive value for cancer 1
• If endometrium ≥5mm or cannot be adequately visualized: Endometrial sampling is mandatory 1
• In premenopausal women: No validated endometrial thickness cutoff exists; base sampling decision on risk factors for endometrial cancer 1
• Consider MRI when ultrasound cannot visualize endometrium due to adenomyosis or leiomyomas 1

Step 3: Tailor Treatment to Symptoms and Fertility Goals

For heavy menstrual bleeding:

• Levonorgestrel intrauterine system (first-line)
• Tranexamic acid
• Combined oral contraceptives
• Progestins (dienogest or others) 7

For pain (especially external adenomyosis):

• NSAIDs
• Hormonal suppression with progestins or GnRH analogues
• Consider evaluation for coexisting deep endometriosis 2, 7

For fertility concerns:

• Adenomyosis prevalence reaches 38.2% in recurrent pregnancy loss 3
• Conservative surgical excision may be considered in select cases
• Careful preconception counseling regarding obstetric risks 7, 3

Definitive treatment:

• Hysterectomy remains gold standard for histologic diagnosis and definitive cure
• Uterine artery embolization for uterine preservation
• High-intensity focused ultrasound (HIFU) 7, 3

Step 4: Follow-Up Imaging

When to repeat imaging 1:

• Sonohysterography to characterize focal endometrial abnormalities
• MRI pelvis with contrast when initial ultrasound inconclusive
• Serial ultrasound to monitor treatment response (hormonal therapy reduces number of ultrasound criteria) 2

Important Caveats

• Hormonal treatment affects ultrasound appearance: Patients on hormonal therapy show fewer ultrasound criteria and reduced symptoms 2
• Pregnancy changes everything: Ultrasound diagnosis becomes challenging during pregnancy due to physiological uterine changes; management is conservative with symptom control 3
• Don't rely on indirect signs alone: Specificity >97% but sensitivity is very low; use as supportive findings only 4
• CT has no role in adenomyosis evaluation 1

The diagnosis of adenomyosis on ultrasound should prompt symptom assessment and risk stratification rather than automatic intervention, as approximately one-third of patients are asymptomatic and require no treatment beyond surveillance 3.